More Clarity This update is a clearer indication as to what the future holds for the shareholders. We are not looking at the licensing of our drug to Bryden while he cuts a deal with a big Pharma. We are on life support at 40 grand a month while management searches for a BUYER of our lead drug over the next three years. Bryden may be the ultimate buyer to take this into private hands. Where does that leave shareholders? Is there any value in the company without the lead drug? I think the most likely scenario would be the sale to private equity of the whole company so the future buyer could use the tax losses.
The only question left is what is our patented drug worth? Our market cap is $5 million. Do I hear $10 ? Going once at 5. Are you all in?
Alan